Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bayer's Nexavar approved for primary liver cancer by NICE

pharmatimesAugust 11, 2017

Tag: Bayer , NICE , Nexavar (sorafenib) , Cancer Drugs Fund

PharmaSources Customer Service